OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart failure: when form fails to follow function
Arnold M. Katz, Ellis L. Rolett
European Heart Journal (2015) Vol. 37, Iss. 5, pp. 449-454
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
Zhipeng Cao, Yuqing Jia, Bao-Li Zhu
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1820-1820
Open Access | Times Cited: 281

The continuous heart failure spectrum: moving beyond an ejection fraction classification
Filippos Triposkiadis, Javed Butler, François M. Abboud, et al.
European Heart Journal (2019) Vol. 40, Iss. 26, pp. 2155-2163
Open Access | Times Cited: 230

Cardiac aging and heart disease in humans
Marja Steenman, Gilles Lande
Biophysical Reviews (2017) Vol. 9, Iss. 2, pp. 131-137
Open Access | Times Cited: 207

Autophagy in Cardiovascular Aging
Mahmoud Abdellatif, Simon Sedej, Didac Carmona‐Gutiérrez, et al.
Circulation Research (2018) Vol. 123, Iss. 7, pp. 803-824
Open Access | Times Cited: 201

Cardiovascular Disease in Ageing: An Overview on Thoracic Aortic Aneurysm as an Emerging Inflammatory Disease
Calogera Pisano, Carmela Rita Balistreri, Alessandro Ricasoli, et al.
Mediators of Inflammation (2017) Vol. 2017, pp. 1-8
Open Access | Times Cited: 192

Cardiac fibroblasts and mechanosensation in heart development, health and disease
Maurizio Pesce, Georg N. Duda, Giancarlo Forte, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 5, pp. 309-324
Closed Access | Times Cited: 72

Novel Mitochondria-Targeting Peptide in Heart Failure Treatment
Melissa A. Daubert, Eric Yow, G. Dewey Dunn, et al.
Circulation Heart Failure (2017) Vol. 10, Iss. 12
Open Access | Times Cited: 148

Artificial Intelligence in Heart Failure: Friend or Foe?
Angeliki Bourazana, Αndrew Xanthopoulos, Αlexandros Briasoulis, et al.
Life (2024) Vol. 14, Iss. 1, pp. 145-145
Open Access | Times Cited: 12

Aerobic Exercise Attenuates Pressure Overload–Induced Myocardial Remodeling and Myocardial Inflammation via Upregulating miR-574-3p in Mice
Qiaoying Chen, Yina Jiang, Xuan Guan, et al.
Circulation Heart Failure (2024) Vol. 17, Iss. 3
Closed Access | Times Cited: 9

The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart
Raffaele Altara, Ziad Mallat, George W. Booz, et al.
Journal of Immunology Research (2016) Vol. 2016, pp. 1-12
Open Access | Times Cited: 80

Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial
Javed Butler, Muhammad Shahzeb Khan, Stefan D. Anker, et al.
Journal of Cardiac Failure (2020) Vol. 26, Iss. 5, pp. 429-437
Open Access | Times Cited: 68

Left ventricular remodeling and dysfunction in primary aldosteronism
Cheng‐Hsuan Tsai, Chien‐Ting Pan, Yi‐Yao Chang, et al.
Journal of Human Hypertension (2020) Vol. 35, Iss. 2, pp. 131-147
Open Access | Times Cited: 67

The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders
Éric Marsault, Catherine Llorens‐Cortès, Xavier Iturrioz, et al.
Annals of the New York Academy of Sciences (2019) Vol. 1455, Iss. 1, pp. 12-33
Open Access | Times Cited: 55

The Role of Adipose Triglyceride Lipase and Cytosolic Lipolysis in Cardiac Function and Heart Failure
Ulrich Kintscher, Anna Foryst‐Ludwig, Guenter Haemmerle, et al.
Cell Reports Medicine (2020) Vol. 1, Iss. 1, pp. 100001-100001
Open Access | Times Cited: 51

HINT1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing HOXA5 (Homeobox A5) Expression
Yan Zhang, Qiang Da, Siyi Cao, et al.
Circulation (2021) Vol. 144, Iss. 8, pp. 638-654
Open Access | Times Cited: 44

Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure
Filippos Triposkiadis, Αndrew Xanthopoulos, John Skoularigis, et al.
Heart Failure Reviews (2022) Vol. 27, Iss. 6, pp. 1991-2003
Closed Access | Times Cited: 31

Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases
Danni Mu, Jin Cheng, Ling Qiu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 28

Crotonylation of NAE1 Modulates Cardiac Hypertrophy via Gelsolin Neddylation
Jie Ju, Kai Wang, Fang Liu, et al.
Circulation Research (2024) Vol. 135, Iss. 8, pp. 806-821
Closed Access | Times Cited: 7

The TRPA1 Channel in the Cardiovascular System: Promising Features and Challenges
Zhen Wang, Di Ye, Jing Ye, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 54

The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions
Anne Pernille Ofstad, Dan Atar, Lars Gullestad, et al.
Heart Failure Reviews (2018) Vol. 23, Iss. 3, pp. 303-323
Open Access | Times Cited: 51

Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers
Alexander Е. Berezin
Journal of Circulating Biomarkers (2016) Vol. 5, pp. 6-6
Open Access | Times Cited: 48

Page 1 - Next Page

Scroll to top